info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Abscess of spleen

D3_ABSCESSSPLEEN

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D73.3
  • Hospital discharge: ICD-8 28940
  • Cause of death: ICD-10 D73.3
  • Cause of death: ICD-8 28940

2 out of 7 registries used, show all original rules.

24

4. Check minimum number of events

None

24

5. Include endpoints

None

24

6. Filter based on genotype QC (FinnGen only)

24

Control definitions (FinnGen only)

Control exclude
D3_BLOODOTHER

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D73
Name in latin
Abscessus lienis

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 241 112 126
Only index persons 195 96 99
Unadjusted period prevalence (%)
Whole population 0.00 0.00 0.00
Only index persons 0.00 0.00 0.00
Median age at first event (years)
Whole population 61.71 64.23 59.49
Only index persons 59.84 62.88 56.90

-FinnGen-

Key figures

All Female Male
Number of individuals 24 12 12
Unadjusted period prevalence (%) 0.00 0.00 0.01
Median age at first event (years) 66.68 67.49 65.88

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3042936) Bacteria identified in Isolate by Culture
15
28
12.41
7.18
5.3
1.9
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
8
6
18.97
5.53
21.8
5.2
mmol/l
9.8
9.6
—
8
6
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
9
14
9.52
4.48
1.8
1.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
12
38
5.32
3.84
2.3
1.6
nmol/l
915.4
1212.1
—
7
28
(42870588) Differential panel, method unspecified - Blood
15
66
4.37
3.08
8.6
6.0
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
7
14
6.56
2.98
2.9
2.6
g/l
0.3
0.2
—
7
14
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
7
14
6.56
2.98
12.1
1.9
kpa
5.7
4.9
—
7
14
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
16
76
4.29
2.93
3.4
2.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
6
10.07
2.88
1.6
1.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
15
70
4.02
2.68
2.5
2.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
8
7.52
2.49
15.8
1.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
7
19
4.74
2.36
1.6
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
6
15
4.95
2.19
2.0
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
8
29
3.61
2.02
1.3
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
7
23
3.86
1.98
3.4
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
8
31
3.35
1.87
3.4
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
13
67
3.05
1.83
5.9
2.1
u/l
71.7
54.1
0.63
13
61
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
13
4.55
1.81
1.6
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
12
63
2.81
1.58
3.7
3.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
5
16
3.66
1.52
2.2
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
5
17
3.43
1.43
3.6
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
12
67
2.58
1.36
7.0
1.9
—
—
—
0
0
(4035726)
5
18
3.22
1.36
1.2
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
6
25
2.85
1.34
2.0
1.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
14
85
2.55
1.33
2.6
2.0
pmol/l
87.4
106.6
—
9
39
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
15
96
2.49
1.31
10.1
3.6
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
5
19
3.04
1.28
3.0
3.1
e6/l
1.0
0.0
—
5
19
(3018677) aPTT in Platelet poor plasma by Coagulation assay
6
26
2.73
1.27
3.0
2.2
s
25.9
30.3
—
6
26
(40768797) Stomach Pathology biopsy report
7
31
2.76
1.23
1.3
1.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
9
46
2.52
1.22
7.1
3.5
%
98.6
88.3
—
9
46
(3000850) Epithelial cells [#/volume] in Urine
9
47
2.45
1.20
1.4
2.5
e6/l
15.9
4.3
—
9
41
(3021960) Folate [Moles/volume] in Serum or Plasma
10
54
2.46
1.18
2.1
1.5
nmol/l
15.7
25.6
—
10
42
(3003694) ABO and Rh group [Type] in Blood
9
49
2.33
1.16
1.4
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
12
72
2.33
1.12
7.3
2.3
ug/l
285.3
120.2
1.37
12
62
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
9
51
2.22
1.11
6.3
1.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
19
143
2.57
1.11
7.7
5.1
—
—
—
0
0
(3013512) EKG study
11
64
2.33
1.09
4.2
5.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
15
102
2.25
1.08
3.4
2.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
15
102
2.25
1.08
27.1
5.3
mmol/l
1.2
1.2
0.25
15
83
(36304419) Bacteria [Presence] in Urine
9
55
2.01
0.87
2.0
2.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
9
59
1.84
0.66
5.3
4.7
—
—
—
0
0
(3044889) 12 lead EKG panel
17
138
1.79
0.56
5.4
3.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
9
68
1.52
0.45
2.8
3.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
19
163
1.79
0.45
46.6
14.8
%
39.8
40.2
0.08
11
112
(21494755) Public health laboratory ask at order entry panel
0
15
0.00
0.43
0.0
1.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
6
43
1.52
0.39
1.5
5.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
6
45
1.44
0.37
7.0
9.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
10
76
1.54
0.35
2.9
3.5
ng/l
7095.2
2024.1
—
10
63
(4094501)
0
11
0.00
0.22
0.0
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
0
11
0.00
0.22
0.0
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
0
10
0.00
0.22
0.0
1.0
—
—
—
0
0
(4034850)
0
10
0.00
0.22
0.0
5.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
10
84
1.33
0.17
5.1
4.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
6
0.00
0.00
0.0
6.3
—
4.5
—
0
6
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
6
0.00
0.00
0.0
6.3
—
63.0
—
0
6
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(1002224) Polysomnography panel
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020891) Body temperature
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.1
—
16.6
—
0
7
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
7
0.00
0.00
0.0
1.3
—
291.4
—
0
7
(3014051) Protein [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint D3_ABSCESSSPLEEN and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have D3_ABSCESSSPLEEN.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: D3_ABSCESSSPLEEN – Abscess of spleen

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data